TAGCyx Biotechnologies
Business Services · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1-6 Tsurumi-ku, Yokohama, Kanagawa, 230-...Phone Number
+81 2017547793Website
www.tagcyx.comRevenue
<$5 MillionIndustry
About TAGCyx Biotechnologies
TAGCyx Biotechnologies Org Chart
Chief Financial Officer
Is TAGCyx Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on TAGCyx Biotechnologies recently announced quarterly report
Product Launch: Get notified when TAGCyx Biotechnologies launches new products
Click to see if TAGCyx Biotechnologies had a recent Job posting/layoffs
Funding: Get notified immidiatlly once TAGCyx Biotechnologies has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if TAGCyx Biotechnologies is spiking on competitors!
Check if TAGCyx Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at TAGCyx Biotechnologies
TAGCyx Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined TAGCyx Biotechnologies as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
TAGCyx Biotechnologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
TAGCyx Biotechnologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about TAGCyx Biotechnologies.
TAGCyx Biotechnologies Tech Stack
A closer look at the technologies used by TAGCyx Biotechnologies
TAGCyx Biotechnologies News & Media
CAGE Bio, TAGCyx, and PeptiStar Announce Execution of a License Agreement for Development and Commercialization of TAGX-0003 for the Treatment of Immunodermatology Diseases Mediated by the IFN-Gamma Pathway
CAGE Bio Inc. (hereinafter "CAGE Bio"), a biotechnology company focused on developing innovative therapies for infection, inflammation and immunology and TAGCyx Biotechnologies Inc. (hereinafter "TAGCyx"), a biotechnology company developing DNA aptamer drugs based on its proprietary artificial nucleic acid base pair technology, announce the execution of a license agreement for development of TAGX-0003 for the targeted treatment of alopecia areata
Top Business Services Companies
Frequently Asked Questions Regarding TAGCyx Biotechnologies
TAGCyx Biotechnologies specializes in the research and development of high-performance nucleic acid drugs, utilizing proprietary nucleic acid technology to create candidate compounds with high affinity and specificity for target molecules. Their product pipeline includes treatments for various conditions such as interstitial cystitis, dry eye syndr... Read More